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■ EDITORIAL ■
The incidence of abnormal placentation, including
placenta accreta, increta and percreta, ranges from 1
in 540 to 1 in 93,000 deliveries [1]. A study clarified
the incidence of placenta previa increta/percreta in a
large-scale series of pregnancies in Japan, with an
observed prevalence of 1 in 2,565 deliveries [2]. Placenta
percreta is the most serious of placental implantation
anomalies beyond the uterine serosa. It can unexpect-
edly lead to catastrophic blood loss, multiple compli-
cations such as adult respiratory distress syndrome,
Sheehan’s syndrome, renal failure, and even death.
Maternal mortality and morbidity are significantly
increased by placenta percreta. The mortality can be
as high as 10% [3]. The morbidity included bladder
laceration (20%), urinary fistula (13%), ureteral tran-
section (6%), and a resulting small bladder capacity
(4%). Partial cystectomy was performed in 44% of
cases [4]. There is a need for reliable antenatal diag-
nosis for these serious conditions. If these pregnancies
can be identified before delivery, the site and time of
delivery as well as the surgical approach can be
planned ahead and decrease the blood loss.
We know that 75% of placenta percreta cases are
associated with placenta previa. Approximately 25% of
women with placenta previa and one previous cesarean
delivery have an accreta/percreta, whereas almost 50%
with placenta previa and two prior cesarean deliveries
have placenta accreta/percreta [5]. Placenta increta/
percreta can only be diagnosed at the time of delivery,
or may be suggested antenatally by ultrasonographic or
magnetic resonance imaging findings in patients whose
clinical history, such as a previous abdominal delivery,
previous uterine surgery, a suction dilatation and curet-
tage, or placenta previa, raises a suspicion [6]. Until
recently, two-dimensional (2D) ultrasonography (US)
remained the standard screening tool for the diagnosis
of invasive placentation. Currently, there is a lack of
data about the accuracy of prenatal diagnosis of pla-
centa increta/percreta. The antenatal detection rate of
placenta accreta (a collective term for accreta, increta
and percreta) on ultrasound varies in the literature,
ranging from 33% (4/12) [5] to 100% (5/5) [7].
In this issue, Chou et al [8] reports that seven of
the 45 patients exhibited characteristic 2D US findings
for placenta increta/percreta. The 2D US criteria for
placenta increta/percreta included placental lacunae,
absence of the retroplacental clear zone, and interrup-
tion of posterior bladder wall–uterine interface. Among
these seven patients of advanced invasive placenta-
tion, a targeted scan with adjunctive three-dimensional
(3D) US correctly provided additional convincing infor-
mation to the indeterminate diagnosis by 2D US in
these patients who were affected with variable degrees
of bladder wall involvement found at surgery. The ten-
tative proposed 3D US criteria for advanced invasive
placentation of suspected bladder involvement are as
follows: (1) a loss of the echolucent space between the
bladder and the placenta in coronal and axial scans;
(2) invasion of the bladder by the infiltrating placenta
with irregularity and disruption of the normal bladder
wall architecture and/or a focal exophytic placental
mass projecting into the bladder in coronal and axial
scans; and (3) aberrant blood vessels in the spatial
vascular network in the region of interest extending
into the bladder by rotational angiography [8,9]. The
authors concluded that 3D US may be a useful adjunc-
tive tool in refining 2D ultrasonographic techniques 
to identify the extent and degree of placental invasion
of the bladder. Finally, Chou et al did not calculate the
antenatal detection rate of placenta increta and per-
creta on ultrasound. A recent publication by Shih and
colleagues [10] assessed the role of 3D power Doppler
in the antenatal diagnosis of placenta accreta and
compared its diagnostic performance with grayscale
and color Doppler US. The final results revealed that
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placenta accreta and its variants (including increta and
percreta) were confirmed in 39 patients at the time of
cesarean delivery. Based on receiver-operating charac-
teristics analysis, “numerous coherent vessels” visual-
ized using 3D power Doppler in the basal view was the
best single criterion for the diagnosis of placenta ac-
creta, with a sensitivity of 97% and a specificity of 92%.
If Shih et al [10] considered the presence of at least one
criterion to be diagnostic when using each ultrasound
technique, then 3D power Doppler would have the best
positive predictive value (76%), followed by grayscale
(51%) and color Doppler (47%).
Chou et al [9] recommended that timely pregnancy
termination is an appropriate management option
because of decreased morbidity and mortality. In this
issue, two patients received total hysterectomy and the
other five received cesarean hysterectomy among those
seven patients. Three patients had morbidity: one had
focal bladder wall resection and repair, one had inad-
vertent ureteral injury with primary repair and reanas-
tomosis of the right ureter, and the last had rebleeding
from the bladder base. The total blood loss was from
850mL to 20,000mL. Attempted forcible ablation of pla-
centa increta/percreta almost always necessitates hys-
terectomy to achieve hemostasis or even the partial
resection of adjoining organs. For this reason, several
reports of conservative treatment of placenta percreta
have already been published [6,11]. Timmermans et al
[11] reviewed the efficacy and safety of conservative
management of abnormally invasive placentation.
From 1985 through 2006, 48 reports have described
the outcomes of 60 women who were treated conser-
vatively for abnormally invasive placentation. Overall,
of the 60 women, 11 experienced infection, 21 experi-
enced vaginal bleeding and four suffered disseminated
intravascular coagulopathy. Spontaneous loss of pla-
cental tissue was noted in 16 women. Subsequent preg-
nancies were reported in eight women. The authors
concluded that conservative management of abnor-
mally invasive placentation can be effective and fertil-
ity can be preserved. It should only be considered in
highly selected cases in which blood loss is minimal
and there is desire for fertility preservation. Conservative
treatment of placenta increta/percreta should be a
safe alternative management.
In conclusion, grayscale, color Doppler and 3D
power Doppler US remain the standard screening tool
for the diagnosis of invasive placentation. 3D power
Doppler would have the best positive predictive value
(76%), followed by grayscale (51%) and color Doppler
(47%) [10]. In some cases, magnetic resonance imaging
may be a useful adjunct to ultrasound in diagnosing
invasive placentation prenatally [12].
References
1. Breen JL, Neubecker R, Gregori CA, Franklin JE Jr. Placenta
accreta, increta, and percreta: a survey of 40 cases. Obstet
Gynecol 1977;49:43–7.
2. Sumigama S, Itakura A, Ota T, et al. Placenta previa 
increta/percreta in Japan: a retrospective study of ultra-
sound findings, management and clinical course. J Obstet
Gynaecol Res 2007;33:606–11.
3. Price FV, Resnik E, Heller KA, Christopherson WA. Placenta
previa percreta involving the urinary bladder: a report of
two cases and review of the literature. Obstet Gynecol 1991;
78:508–11.
4. Hudon L, Belfort MA, Broome DR. Diagnosis and manage-
ment of placenta percreta: a review. Obstet Gynecol Surv 1998;
53:509–17.
5. Finberg HJ, Williams JW. Placenta accreta: prospective
sonographic diagnosis in patients with placenta previa and
prior cesarean section. J Ultrasound Med 1992;11:333–43.
6. Yee YH, Kung FT, Yu PC, Hsu TY, Cheng YF. Successful 
conservative management of placenta previa totalis and
extensive percreta. Taiwan J Obstet Gynecol 2008;47:431–4.
7. Lam G, Kuller J, McMahon M. Use of magnetic resonance
imaging and ultrasound in the antenatal diagnosis of pla-
centa accreta. J Soc Gynecol Investig 2002;9:37–40.
8. Chou MM, Chen WC, Tseng JJ, Chen YF, Yeh TT, Ho ES.
Prenatal detection of bladder wall involvement in invasive
placentation with sequential two-dimensional and adjunc-
tive three-dimensional ultrasonography. Taiwan J Obstet
Gynecol 2009;48:38–45.
9. Chou MM, Tseng JJ, Ho ES, Hwang JI. Three-dimensional
color power Doppler imaging in the assessment of utero-
placental neovascularization in placenta previa increta/
percreta. Am J Obstet Gynecol 2001;185:1257–60.
10. Shih JC, Palacios Jaraquemada JM, Su YN, Shyu MK, Lin
CH, Lin SY, Lee CN. Role of three-dimensional power
Doppler in the antenatal diagnosis of placenta accreta:
comparison with gray-scale and color Doppler techniques.
Ultrasound Obstet Gynecol 2009;33:193–203.
11. Timmermans S, van Hof AC, Duvekot JJ. Conservative man-
agement of abnormally invasive placentation. Obstet Gynecol
Surv 2007;62:529–39.
12. Lax A, Prince MR, Mennitt KW, Schwebach JR, Budorick
NE. The value of specific MRI features in the evaluation of
suspected placental invasion. Magn Reson Imaging 2007;
25:87–93.
Taiwan J Obstet Gynecol • March 2009 • Vol 48 • No 12
T.Y. Hsu
